Clinical Trials Directory

Trials / Conditions / Hepatitis E

Hepatitis E

22 registered clinical trials studyying Hepatitis E — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingRisk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
NCT07358910
Institut Pasteur du Cambodge—
Not Yet RecruitingSerological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-b
NCT06859619
University Hospital, MontpellierN/A
RecruitingExposure to Hepatitis E Virus in Occitania, France
NCT06137313
University Hospital, Toulouse—
UnknownLong-term Effectiveness of a Recombinant Hepatitis E Vaccine
NCT05976594
Xiamen University—
CompletedSafety and Immunogenicity Study of Thiomersal-free Hepatitis E Vaccine in People Ages 16 Years and Above
NCT06564116
Xiamen Innovax Biotech Co., LtdPhase 4
RecruitingMolecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors
NCT06457438
University Hospital OstravaN/A
CompletedSafety Study of Hepatitis E Vaccine (HEV239)
NCT03827395
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
CompletedA Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial)
NCT03365921
Xiamen Innovax Biotech Co., LtdPhase 4
UnknownHEV in Patients With Acute Non-A, Non-B, Non-C Hepatitis in Al-Rajhy University Hospital for Liver
NCT03488589
Mahmoud Abdel Rahman—
CompletedSeroprevalence Hepatitis E Infection in Healthy Blood Donors
NCT03601221
Ente Ospedaliero Cantonale, Bellinzona—
CompletedHepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)
NCT03282474
Hannover Medical SchoolPhase 2
CompletedA Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)
NCT03168412
Xiamen Innovax Biotech Co., LtdPhase 4
CompletedA Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Pat
NCT02964910
Xiamen Innovax Biotech Co., LtdPhase 4
CompletedSeroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)
NCT02847507
Centre Hospitalier de la côte Basque—
TerminatedRibavirin for Severe Acute and Chronic Hepatitis E Virus Infection.
NCT02558114
Hospital Universitari Vall d'Hebron Research InstitutePhase 4
CompletedA Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recom
NCT02584543
Xiamen Innovax Biotech Co., LtdPhase 4
CompletedA Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults
NCT02603055
Jiangsu Province Centers for Disease Control and PreventionPhase 1
CompletedA Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)
NCT02417597
Xiamen Innovax Biotech Co., LtdPhase 4
CompletedSeroprevalence of Hepatitis E in People With an Organ Transplant
NCT02190253
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)—
CompletedPhase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）
NCT02189603
Jun ZhangPhase 4
CompletedMorbidity and Mortality of Hepatitis E Virus Infections in Belgium
NCT04670419
University Hospital, Antwerp—
CompletedClinical Trial of Recombinant Hepatitis E Vaccine
NCT01014845
Xiamen UniversityPhase 3